Analysis & Opinion
Is it time to admit that Israeli settlements are here to stay?
That will depend on whether Palestinians as well as Israelis are ready to embrace a one-state solution
Why are Jerusalem’s 300,000 Arabs rising up again?
The eruptions are about much more than just Haram al-Sharif, also known as Temple Mount.
Documents raise fresh questions about thalidomide criminal trial
Papers recently unearthed by the UK’s Thalidomide Trust will surely stoke fresh controversy about how and why the criminal trial against the drug’s makers ended without a verdict in December 1970.
U.S. ‘soft power’ hits another hard reality in the Middle East
Nowhere in the globe does idealism face a more testing challenge than in the Middle East -- now burying the last hopeful remains of the Arab Spring.
Oil price plummet won’t help U.S. with Iran or Russia
Plummeting oil prices — down more than 25 percent since June to three-year lows — should relieve pressure on consumers at the pump. But is it pushing oil-exporting regimes past the breaking point?
Novel suit to determine if soldiers can sue over wartime terrorism
A new complaint claims that Barclays, Standard Chartered, HSBC, Credit Suisse and RBS conspired with Iranian banks to facilitate financial transactions by militant groups targeting U.S. troops during the Iraq conflict. The plaintiffs will have to show that the alleged Iranian-sponsored attacks weren't acts of war.
Should Obamacare be derailed by a single sentence?
Most disputes that end up at the U.S. Supreme Court are about the interpretation of the Constitution and statutes, not about facts. The press is mostly left to provide the basic background of the dispute and then quote each side’s lawyers. Little independent digging is required.THE LATEST
- Buffett’s $4.7 bln Duracell deal a double positive
by Robert Cyran | Thu, Nov 13, 2014, 7:38 PM UTC - The latest in restrictive corporate bylaws: Small shareholders can’t sue
by Alison Frankel | Thu, Nov 13, 2014, 8:36 PM UTC - Documents raise fresh questions about thalidomide criminal trial
by Harold Evans | Thu, Nov 13, 2014, 10:22 PM UTC - Heady Topper points to beer business peak
by Rob Cox | Thu, Nov 13, 2014, 4:13 PM UTC - SABMiller has fight to justify heady share price
by Robert Cole | Thu, Nov 13, 2014, 2:34 PM UTC - Bollywood makes up for years of bias against women
by Shilpa Jamkhandikar | Thu, Nov 13, 2014, 7:50 AM UTC - Is it time to admit that Israeli settlements are here to stay?
by Dimi Reider | Thu, Nov 13, 2014, 2:53 PM UTC - UK election – a race to the bottom?
by Mike Peacock | Thu, Nov 13, 2014, 7:58 AM UTC - Tencent’s mobile boom is more than just games
by Robyn Mak | Thu, Nov 13, 2014, 6:15 AM UTC - Why are Jerusalem’s 300,000 Arabs rising up again?
by Rashid I. Khalidi | Thu, Nov 13, 2014, 11:15 AM UTC
COLUMNISTS & CONTRIBUTORS
-
Thu, Nov 13, 2014, 10:22 PM UTC
Documents raise fresh questions about thalidomide criminal trial
-
Thu, Nov 13, 2014, 2:53 PM UTC
Is it time to admit that Israeli settlements are here to stay?
-
Thu, Nov 13, 2014, 11:15 AM UTC
Why are Jerusalem’s 300,000 Arabs rising up again?
-
Wed, Nov 12, 2014, 8:43 PM UTC
U.S. ‘soft power’ hits another hard reality in the Middle East
-
Tue, Nov 11, 2014, 7:27 PM UTC
Should Obamacare be derailed by a single sentence?
-
-
Thu, Nov 13, 2014, 7:38 PM UTC
Buffett’s $4.7 bln Duracell deal a double positive
-
Thu, Nov 13, 2014, 4:13 PM UTC
Heady Topper points to beer business peak
-
Thu, Nov 13, 2014, 2:34 PM UTC
SABMiller has fight to justify heady share price
-
Thu, Nov 13, 2014, 6:15 AM UTC
Tencent’s mobile boom is more than just games
-
Wed, Nov 12, 2014, 7:46 PM UTC
Barclays’ forex delay looks like bad news
-
59
commentsIs saying hello sexual harassment?